Acceptance and Commitment Therapy (ACT) Adapted for Women With Infertility-related Distress

April 3, 2025 updated by: Jennifer Gordon, University of Regina

Randomized Control Trial of Acceptance and Commitment Therapy Adapted for Women With Infertility-related Distress

This RCT will test the effect of a 7-week self-help ACT-based program in improving fertility-related quality of life and psychological flexibility, in women with infertility.

Study Overview

Status

Completed

Conditions

Detailed Description

Ninety women with infertility living in Canada and the United States will be recruited. They will be emailed seven weekly 15-minute videos, each providing instructions on a new Acceptance and Commitment Therapy-based technique that addresses the impact of infertility on psychological inflexibility and distress. Fertility-related quality of life and psychological flexibility will be measured before and after the program. Outcomes will also be measured at one-month follow-up. Feedback about how to improve the program will also be collected.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Saskatchewan
      • Regina, Saskatchewan, Canada, S4S 0A2
        • University of Regina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 42 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Has been trying to get pregnant for 12+ months and has failed OR is currently undergoing fertility treatments
  • Lives in Canada or the United States
  • Reports a high level of distress related to infertility, as indicated by a FertiQoL score below 71

Exclusion Criteria:

  • Is currently experiencing active suicidal ideation, as indicated by a score of 7 or above on the Suicide Behaviours Questionnaire - Revised (SBQ-R)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The program consists of brief weekly videos, each addressing a particular Acceptance and Commitment Therapy technique to be implemented that week. Participants receive the videos by email from the researcher and watch them on their own. Each video also assigns a "homework" exercise for the participant to complete that week and includes a summary of the module.
Seven 15-minutes videos of Acceptance and commitment therapy adapted for women with infertility with assigned homework and summaries of the videos.
No Intervention: Waistlist
Participants in the waitlist control condition will complete the same measures as the intervention group. After they have completed their one-month follow-up measures they will be given the opportunity to receive the intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fertility Quality of Life tool (Fertiqol)
Time Frame: Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
Pre-to-post change in quality of life related to a diagnosis of infertility. Scores range from 0-100, with higher scores indicating better quality of life.
Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
Psychological flexibility (MPFI)
Time Frame: Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
Pre-to-post change in psychological flexibility. Higher scores on the flexibility sub scale indicating better psychological flexibility.
Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
Pre-to-post change in anxious symptoms; Scores range from 0-21, with higher scoresindicating more severe anxiety
Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)
Pre-to-post change in depressive symptoms; Scores range from 0-27, with higherscores indicating more severe depressive symptoms
Pre-to-post intervention change and in the month following the intervention (post measures assessed 4 weeks after receipt of last module)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2023

Primary Completion (Actual)

November 1, 2023

Study Completion (Actual)

December 1, 2023

Study Registration Dates

First Submitted

October 14, 2022

First Submitted That Met QC Criteria

October 14, 2022

First Posted (Actual)

October 18, 2022

Study Record Updates

Last Update Posted (Actual)

April 8, 2025

Last Update Submitted That Met QC Criteria

April 3, 2025

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility, Female

Clinical Trials on Infertility ACTion Program

Subscribe